URI
65
5
DD
63
3
WY
54
4
ADSK
70
2
VZ
50
3
CAH
48
-5
KLAC
47
4
LRCX
43
-2
WBA
48
4
SE
61
-4
URBN
56
14
GOOGL
40
-5
MPC
44
-3
INTU
56
-4
YUM
47
3
PGR
65
2
FDX
43
3
IBM
58
-2
MRK
25
-2
EXC
53
-3
URI
65
5
DD
63
3
WY
54
4
ADSK
70
2
VZ
50
3
CAH
48
-5
KLAC
47
4
LRCX
43
-2
WBA
48
4
SE
61
-4
URBN
56
14
GOOGL
40
-5
MPC
44
-3
INTU
56
-4
YUM
47
3
PGR
65
2
FDX
43
3
IBM
58
-2
MRK
25
-2
EXC
53
-3
Financhill
Back

Addex Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18

ADXN
Addex Therapeutics

Last Price:
7.58
Seasonality Move:
43.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Addex Therapeutics Price Quote

$7.58
+0.05 (+-6.54%)
(Updated: November 23, 2024 at 5:23 AM ET)

Addex Therapeutics Key Stats

Sell
18
Addex Therapeutics (ADXN) is a Sell
Day range:
$7.01 - $8.98
52-week range:
$5.00 - $27.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.17
P/B ratio:
0.57%
Volume:
37.5K
Avg. volume:
46.7K
1-year change:
34.46%
Market cap:
$8M
Revenue:
$1.8M
EPS:
$-1.64

How Much Does Addex Therapeutics Make?

Is Addex Therapeutics Growing As A Company?

  • What Is Addex Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.82%
  • What Is Addex Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Addex Therapeutics Stock Price Performance

What Is Addex Therapeutics 52-Week High & Low?

Addex Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Addex Therapeutics?

Is Addex Therapeutics Cash Flow Positive?

  • What Is ADXN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.7M
  • What Is Addex Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$151K
  • What Is Addex Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $5.2M

Addex Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADXN return on invested capital is 90.28%
  • What Is Addex Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 54.9%
  • What Is ADXN Return On Equity?
    ROE is a measure of profitability and is 90.28%

Addex Therapeutics Earnings Date & Stock Price

Addex Therapeutics Competitors

Addex Therapeutics Dividend Yield

Addex Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -81.84% -49.38%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 298.41%

Major Shareholders

  • How many ADXN shares are owned by institutional investors?
    4.6M ADXN shares are owned by institutional investors
  • How many ADXN shares are owned by insiders?
    0 ADXN shares are owned by insiders